|
|
???tair.name??? >
???browser.page.title.author???
|
"pan sl"???jsp.browse.items-by-author.description???
Showing items 11-35 of 123 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2015 |
MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27
|
Pai, HC;Kumar, S;Shen, CC;Liou, JP;Pan, SL;Teng, CM |
| 臺北醫學大學 |
2015 |
The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor
|
Tzeng, HE;Yang, L;Chen, K;Wang, Y;Liu, YR;Pan, SL;Gaur, S;Hu, S;Yen, Y. |
| 臺北醫學大學 |
2015 |
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo
|
Huang, HL;Peng, CY;Lai, MJ;Chen, CH;Lee, HY;Wang, JC;Liou, JP;Pan, SL;Teng, CM. |
| 臺北醫學大學 |
2015 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells
|
Liu, YM;Lee, HY;Chen, CH;Lee, CH;Wang, LT;Pan, SL;Lai, MJ;Yeh, TK;Liou, JP. |
| 中國醫藥大學 |
2014-12 |
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.
|
(Huang HL);彭婕妤(Chieh-Yu Peng);(Lai MJ);(Chen CH);(Lee HY);(Wang JC);(Liou JP)*;(Pan SL)*;(Teng CM)* |
| 國家衛生研究院 |
2014-05 |
Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells
|
Lee, HY;Tsai, AC;Chen, MC;Shen, PJ;Cheng, YC;Kuo, CC;Pan, SL;Liu, YM;Liu, JF;Yeh, TK;Wang, JC;Chang, CY;Chang, JY;Liou, JP |
| 國家衛生研究院 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL |
| 臺北醫學大學 |
2014 |
Does non-central nervous system tuberculosis increase the risk of ischemic stroke? A population-based propensity score-matched follow-up study
|
Wu, CH;Chen, LS;Yen, MF;Chiu, YH;Fann, CY;Chen, HH;Pan, SL |
| 臺北醫學大學 |
2014 |
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I
|
Yu, CC;Pan, SL;Chao, SW;Liu, SP;Hsu, JL;Yang, YC;Li, TK;Huang, WJ;Guh, JH. |
| 臺北醫學大學 |
2014 |
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
|
Lee, HY;Tsai, AC;Chen, MC;Shen, PJ;Cheng, YC;Kuo, CC;Pan, SL;Liu, YM;Liu, JF;Yeh, TK;Wang, JC;Chang, CY;Chang, JY;Liou, JP. |
| 臺北醫學大學 |
2014 |
NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells
|
Wu, SY;Pan, SL;Xiao, ZY;Hsu, JL;Chen, MC;Lee, KH;Teng, CM |
| 臺北醫學大學 |
2014 |
Novel electrospun microtube array membrane
|
Tseng, CH;Chiu, CC;Chen, KS;Hsiao, G;Pan, SL;Chen, CC |
| 臺北醫學大學 |
2014 |
Cell adhesion enhancement of electrospun microtube array membrane
|
Tseng, CH;Chang, CT;Chen, KS;Hsiao, G;Pan, SL;Chen, CC |
| 臺北醫學大學 |
2014 |
A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin
|
Wang, LT;Liou, JP;Li, YH;Liu, YM;Pan, SL;Teng, CM |
| 臺北醫學大學 |
2014 |
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 臺北醫學大學 |
2014 |
K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2
|
Lee, HY;Wang, LT;Li, YH;Pan, SL;Chen, YL;Teng, CM;Liou, JP |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 臺北醫學大學 |
2014 |
Responsiveness of SF-36 and Lower Extremity Fubctional Scale for assesing outcomes in traumatic injuries of lower extremities injury
|
Pan, SL;Hou, WH;Yeh, TS;Liang, HW |
| 臺北醫學大學 |
2014 |
Moniliformediquinone induces in vitro and in vivo antitumor activity through glutathione-involved DNA damage response and mitochondrial stress in human hormone-refractory prostate cancers
|
Hsu, JL;Lee, YJ;Leu, WJ;Dong, YS;Pan, SL;Uang, BJ;Guh, JH. |
| 臺北醫學大學 |
2014 |
In vitro and in vivo antitumor effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 國家衛生研究院 |
2013-09 |
Furanylazaindoles: Potent anticancer agents in vitro and in vivo
|
Lee, HY;Pan, SL;Su, MC;Liu, YM;Kuo, CC;Chang, YT;Wu, JS;Nien, CY;Mehndiratta, S;Chang, CY;Wu, SY;Lai, MJ;Chang, JY;Liou, JP |
| 國家衛生研究院 |
2013-08 |
Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF-alpha–induced TGF-alpha expression and MEK/VEGF-A–mediated angiogenesis
|
Chang, LH;Pan, SL;Lai, CY;Tsai, AC;Teng, CM |
| 國家衛生研究院 |
2013-04-07 |
BPR000K, a novel Aurora kinase inhibitor
|
Chao, YS;Hsu, JTA;Chen, CT;Yeh, TK;Pan, SL;Hsieh, HP |
| 國家衛生研究院 |
2013-04-07 |
Development drug candidate targeting EGFR kinase: DBPR112
|
Sun, HY;Hsu, JTA;Chen, CT;Yeh, TK;Pan, SL;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2013-04 |
MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo
|
Chen, CH;Li, YC;Chang, LH;Liou, JP;Pan, SL;Teng, CM |
Showing items 11-35 of 123 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
